These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 12943703)
1. Gene networks in glucocorticoid-evoked apoptosis of leukemic cells. Webb MS; Miller AL; Johnson BH; Fofanov Y; Li T; Wood TG; Thompson EB J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):183-93. PubMed ID: 12943703 [TBL] [Abstract][Full Text] [Related]
2. Regulation of a distinctive set of genes in glucocorticoid-evoked apoptosis in CEM human lymphoid cells. Thompson EB; Johnson BH Recent Prog Horm Res; 2003; 58():175-97. PubMed ID: 12795419 [TBL] [Abstract][Full Text] [Related]
3. Identification of genes leading to glucocorticoid-induced leukemic cell death. Thompson EB; Webb MS; Miller AL; Fofanov Y; Johnson BH Lipids; 2004 Aug; 39(8):821-5. PubMed ID: 15638253 [TBL] [Abstract][Full Text] [Related]
4. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression. Medh RD; Saeed MF; Johnson BH; Thompson EB Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879 [TBL] [Abstract][Full Text] [Related]
5. Gene expression profile of human lymphoid CEM cells sensitive and resistant to glucocorticoid-evoked apoptosis. Medh RD; Webb MS; Miller AL; Johnson BH; Fofanov Y; Li T; Wood TG; Luxon BA; Thompson EB Genomics; 2003 Jun; 81(6):543-55. PubMed ID: 12782123 [TBL] [Abstract][Full Text] [Related]
6. Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells. Medh RD; Wang A; Zhou F; Thompson EB Oncogene; 2001 Aug; 20(34):4629-39. PubMed ID: 11498786 [TBL] [Abstract][Full Text] [Related]
7. Role of c-jun induction in the glucocorticoid-evoked apoptotic pathway in human leukemic lymphoblasts. Zhou F; Thompson EB Mol Endocrinol; 1996 Mar; 10(3):306-16. PubMed ID: 8833659 [TBL] [Abstract][Full Text] [Related]
8. Sequential gene regulatory events leading to glucocorticoid-evoked apoptosis of CEM human leukemic cells:interactions of MAPK, MYC and glucocorticoid pathways. Webb MS; Miller AL; Howard TL; Johnson BH; Chumakov S; Fofanov Y; Nguyen-Vu T; Lin CY; Thompson EB Mol Cell Endocrinol; 2018 Aug; 471():118-130. PubMed ID: 29596968 [TBL] [Abstract][Full Text] [Related]
10. Role of intracellular free Ca(II) and Zn(II) in dexamethasone-induced apoptosis and dexamethasone resistance in human leukemic CEM cell lines. Adebodun F; Post JF J Cell Physiol; 1995 Apr; 163(1):80-6. PubMed ID: 7896902 [TBL] [Abstract][Full Text] [Related]
11. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor. Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130 [TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of leukemic cells and primary thymocytes predicts a signature for apoptotic sensitivity to glucocorticoids. Miller AL; Komak S; Webb MS; Leiter EH; Thompson EB Cancer Cell Int; 2007 Nov; 7():18. PubMed ID: 18045478 [TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid mediated transcriptional repression of c-myc in apoptotic human leukemic CEM cells. Zhou F; Medh RD; Thompson EB J Steroid Biochem Mol Biol; 2000; 73(5):195-202. PubMed ID: 11070348 [TBL] [Abstract][Full Text] [Related]
14. Honokiol induces apoptosis and autophagy in dexamethasone-resistant T-acute lymphoblastic leukemia CEM-C1 cells. Liu Y; Zhang S; Tan Y Hematology; 2024 Dec; 29(1):2337307. PubMed ID: 38573223 [No Abstract] [Full Text] [Related]
15. Comparison of two structurally diverse glucocorticoid receptor agonists: cortivazol selectively regulates a distinct set of genes separate from dexamethasone in CEM cells. Miller AL; Webb MS; Thompson EB Steroids; 2007 Sep; 72(9-10):673-81. PubMed ID: 17606285 [TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid antagonist RU 486 reverses agonist-induced apoptosis and c-myc repression in human leukemic CEM-C7 cells. Thompson EB; Thulasi R; Saeed MF; Johnson BH Ann N Y Acad Sci; 1995 Jun; 761():261-75. PubMed ID: 7625725 [TBL] [Abstract][Full Text] [Related]
17. Corticosteroid effects on lipid lateral diffusion in CEM-C1 and CEM-C7 acute lymphoblastic leukemia cells. Bulva CJ; Printen J; Melnykovych G; Cutts L; Barisas BG; Roess DA Biochim Biophys Acta; 1991 Aug; 1094(1):134-7. PubMed ID: 1883851 [TBL] [Abstract][Full Text] [Related]
18. A novel method to establish glucocorticoid resistant acute lymphoblastic leukemia cell lines. Gu L; Zhang G; Zhang Y J Exp Clin Cancer Res; 2019 Jun; 38(1):269. PubMed ID: 31221196 [TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid-receptor-gene defects and resistance to glucocorticoid-induced apoptosis in human leukemic cell lines. Hala M; Hartmann BL; Böck G; Geley S; Kofler R Int J Cancer; 1996 Nov; 68(5):663-8. PubMed ID: 8938150 [TBL] [Abstract][Full Text] [Related]
20. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs. Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]